As the global Peptide Therapeutics market is expected to reach over $25 billion by 2018, the market is strongly trying to develop new peptide therapeutics and better formulations to enhance drug delivery. Even though peptides is a relatively niche market – it has a fast growth rate with many products in development. The conference will enable you to assess biophysical characterisation such as solubility and stability in addition to revie...

Overview of the Workshop: The OMB Circular, No. A–11, Part 7 PLANNING, BUDGETING, ACQUISITION, AND MANAGEMENT OF CAPITAL ASSETS says that all major projects will be managed using EVMS as defined in the Capital Programming Guide. That the information will be used to report to status against OMB 300 programs. EVM is a proven project management technique which will provide an early warning of project cost and schedule performance issues. I...

18+ industry case studies on minimising viral contamination risk including new insights from Eli Lilly and Company, Merck Serono, Regeneron Pharmaceuticals and Novartis Pharma AG. Independent analysis from Baxter BioScience on the application and implementation of next-generation detection technologies for rapid virus identification. Genzyme and Sanofi Pasteur evaluate the implementation of upstream viral clearance barriers to reduce the risk...

ICH M7 is due to be finalised at the next ICH meeting on 31 May - 5 June. Strategically timed to share the latest developments, progress and news on the guidance, Informa Life Sciences Genotoxic Impurities conference is only two weeks later (24-25 June 2014)! Do not miss this essential opportunity to find out exactly what made the final guidance from members of the expert working group themselves. Genotoxic Impurities 2014 is dedicated to deli...

This event offers practical guidance on running clinical trials in; Egypt, Jordan, Lebanon, Oman, Qatar, Tunisia, Turkey, United Arab Emirates. This meeting will facilitate business opportunities, showcase local capabilities and connect key stakeholders - 120+ attendees from MENA, Turkey and western Europe regions. We have 40+ expert speakers including local and western-based large pharma and small biotechs. Key themes for Partnerships in Clin...

Utilities across Europe face the prospect of meeting the EU’s goal of installing smart meters for 80% of consumers by 2020. National plans for meeting this target vary considerably across the continent with Italy and Sweden having completed physical roll out without fully utilising smart meter functionality. Gas, electricity, and water suppliers face similar challenges in managing existing meter assets and where appropriate planning for...

International conference bringing together scientists and electrical engineers from universities, research groups and industry working on the development and application of magnetic materials. WMM 2014 will provide a general overview of the status, trends and recent developments in the field of magnetism and magnetic materials and their application. Invited papers will be presented by experts from industry and universities, and a restricted nu...

The FedRAMP deployment deadline is scheduled for June 5, 2014. The Federal Government will then require all cloud providers to have FedRAMP approval. If you miss the deadline there are new templates, new workgroups and new activities that should be part of your FedRAMP planning. This workshop will provide you an understanding the post June 5th FedRAMP cloud strategy and post deadline lessons learned for FedRAMP Security: What You Need to Know...

The European regulatory landscape for medical devices is changing and the new Regulation is expected to have a significant impact on the role of the manufacturer. Through a combination of theory and practical discussion, participants on this course will build on their existing regulatory knowledge to develop improved tactics, ensuring speedy market access and effective lifecycle management of their products.

The European Commission are currently undertaking a further complete Revision (Recast) of the regulatory requirements. Learn about these proposals and the latest developments and how these will affect you in the future.Course Highlights•Gain a complete overview of the latest MDD regulations.•Determine the most appropriate conformance route for your products.•Meet the requirements for clinical data evaluation.•Examine the ro...